Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview

Pancreatic cancer is a devastating disease with the worst outcome of any human cancer. Despite significant improvements in cancer treatment in general, little progress has been made in pancreatic cancer (PDAC), resulting in an overall 5-year survival rate of less than 10%. This dismal prognosis can...

Descripción completa

Detalles Bibliográficos
Autores principales: Slapak, Etienne J., el Mandili, Mouad, Bijlsma, Maarten F., Spek, C. Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876630/
https://www.ncbi.nlm.nih.gov/pubmed/35214121
http://dx.doi.org/10.3390/pharmaceutics14020390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876630/
https://www.ncbi.nlm.nih.gov/pubmed/35214121
http://dx.doi.org/10.3390/pharmaceutics14020390

Ejemplares similares